Anke Mittelstädt

8PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersNephrology and urologySurgeryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.

|Mar 14, 2026
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma.

Alara Karabiber, Yong Zhou, Anke Mittelstädt

|Feb 27, 2026
Beyond Survival: Factors Driving Textbook Outcome After Simultaneous Pancreas-Kidney Transplantation-A Retrospective Analysis.

Anke Mittelstädt, Frederik Weber, Maximilian Brunner

|Jan 10, 2026
Prediction and Risk Evaluation for Surgical Intervention in Small Bowel Obstruction †.

Timur Buniatov, Matthias Maak, Anne Jacobsen

|Nov 13, 2025
The Prognostic Role of Para-Aortic Lymph Node Metastasis in Patients with Resected Pancreatic Adenocarcinoma.

Maximilian Brunner, Lena Kitzke, Anke Mittelstädt

|Apr 17, 2025
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients.

Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie

Pageof 2

Frequent Collaborators

7 joint publications

Georg F Weber

6 joint publications

Christian Krautz

5 joint publications

Susanne Merkel

4 joint publications

Paul David